Trademark: 97028747
Status Date
Tuesday, January 23, 2024
Filing Date
Wednesday, September 15, 2021
Published for Opposition
Tuesday, December 6, 2022
5 pharmaceutical preparations for the diagnosis, prevention and treatment of psychiatric, neurological, hormonal, genetic and endocrine disorders and conditions; pharmaceutical preparations for human use for diagnosis, prevention and treatment of diseases and disorders by gene therapy; pharmaceuticals for human use for the treatment of rare and orphan diseases, disorders and conditions; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia
Jan 25, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 23, 2024
Sou Extension 2 Granted
Jan 23, 2024
Sou Extension 2 Filed
Jan 23, 2024
Sou Teas Extension Received
Jul 28, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 26, 2023
Sou Extension 1 Granted
Jul 26, 2023
Sou Extension 1 Filed
Jul 26, 2023
Sou Teas Extension Received
Jan 31, 2023
Noa E-Mailed - Sou Required From Applicant
Dec 6, 2022
Official Gazette Publication Confirmation E-Mailed
Dec 6, 2022
Published For Opposition
Nov 16, 2022
Notification Of Notice Of Publication E-Mailed
Nov 3, 2022
Approved For Pub - Principal Register
Nov 2, 2022
Teas/Email Correspondence Entered
Nov 2, 2022
Correspondence Received In Law Office
Nov 2, 2022
Teas Response To Office Action Received
May 6, 2022
Notification Of Priority Action E-Mailed
May 6, 2022
Priority Action E-Mailed
May 6, 2022
Priority Action Written
May 3, 2022
Assigned To Examiner
Oct 21, 2021
New Application Office Supplied Data Entered
Sep 18, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
